MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas

Oncology Reports
Xu ZhangGong-Yan Chen

Abstract

Human non-small cell lung carcinoma (NSCLC) is one of the most common cancer worldwide. In previous studies, lovastatin, acting as an inhibitor of 3-hydroxy-3-methylglutaryl Co A (HMG-CoA) reductase, exhibited significant antitumor activity during tumorigenesis. However, whether or not this effect is mediated through changes in minichromosome maintenance (MCM) 2 expression remains unclear. The present study investigated whether lovastatin inhibits proliferation due to MCM2 in NSCLCs. We first assessed the effects of lovastatin on cell anti-proliferation, cell cycle progression and apoptosis in NSCLC cells. We found, by quantitative RT-PCR and western blot analysis, that lovastatin treatment markedly and consistently inhibited the expression of MCM2. Then, to further explore the anticancer mechanism of lovastatin involving MCM2, we silenced MCM2 by siRNA in two cell lines (A549 and GLC-82). Silencing of MCM2 triggered G1/S arrest. Following further examination of cell cycle-related factors, MCM2 knockdown inhibited protein retinoblastoma (Rb), cyclin D1 and CDK4 expression, but increased p21 and p53 expression, suggesting that siMCM2 indeed triggered cell cycle arrest. In addition, siMCM2 induced apoptosis. Finally, lovastatin t...Continue Reading

References

Feb 20, 2003·European Journal of Pharmacology·Dennis BruemmerRonald E Law
Mar 17, 2004·Biochimica Et Biophysica Acta·Marie A BogoyevitchRenae K Barr
Sep 5, 2006·Cancer Research·Michael J CampbellChristopher C Benz
Jan 4, 2008·International Journal of Cancer. Journal International Du Cancer·Hang XiaoChung S Yang
Jan 18, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ashraful HoqueXiao-Chun Xu
Mar 29, 2008·The American Journal of Gastroenterology·Olorunseun O Ogunwobi, Ian L P Beales
Dec 17, 2008·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Yong WangZong-Guang Zhou
Sep 30, 2010·International Journal of Molecular Medicine·Borna ReljaMark Lehnert
Oct 5, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Junko KikuchiHirotoshi Dosaka-Akita
Dec 18, 2010·Lipids in Health and Disease·Giovani M FaveroSergio P Bydlowski
Jan 25, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Toran SanliTheodoros Tsakiridis
Nov 26, 2011·Experimental and Molecular Pathology·Shiho SuzukiMasanobu Kitagawa
Nov 9, 2012·The New England Journal of Medicine·Sune F NielsenStig E Bojesen
Apr 30, 2013·Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists·Qi-chang YangXiao-hua Ji
Jun 19, 2013·Toxicology Letters·Yangbo LiuBo Zhang
Sep 5, 2013·Bioscience Reports·Nicholas SimonAnthony Schwacha
Oct 25, 2013·Protein and Peptide Letters·Chunli PangYong Zhan
Jun 18, 2014·The American Journal of Dermatopathology·Asmaa Gaber AbdouDina Sharaf Eldien

❮ Previous
Next ❯

Citations

Feb 28, 2020·Experimental and Therapeutic Medicine·Hongshi LiLijie He
Apr 14, 2018·Frontiers in Molecular Biosciences·Yeon-Soo Seo, Young-Hoon Kang
May 19, 2020·BioMed Research International·Yajun DengRuochen Zhao
Feb 25, 2020·Analytical Cellular Pathology (Amsterdam)·Si YuYang Chen
Jun 15, 2016·Applied Immunohistochemistry & Molecular Morphology : AIMM·Jelena Stojkovic-FilipovicBranislav Lekic
Oct 19, 2017·Scientific Reports·Chantal Hoi Yin CheungHsueh-Fen Juan
Jan 28, 2021·International Journal of Molecular Sciences·Luca BedonMaurizio Polano
Aug 22, 2020·Biochimica Et Biophysica Acta. Reviews on Cancer·Yifei WangWei Kang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.